Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD
Nobuharu Tamaki, Veeral Ajmera, Rohit Loomba
Nature Reviews Endocrinology (2021) Vol. 18, Iss. 1, pp. 55-66
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Global incidence of non-alcoholic fatty liver disease: A systematic review and meta-analysis of 63 studies and 1,201,807 persons
Michael H. Le, David M. Le, Thomas C. Baez, et al.
Journal of Hepatology (2023) Vol. 79, Iss. 2, pp. 287-295
Closed Access | Times Cited: 155
Impact of non-invasive biomarkers on hepatology practice: Past, present and future
Quentin M. Anstee, Laurent Castéra, Rohit Loomba
Journal of Hepatology (2022) Vol. 76, Iss. 6, pp. 1362-1378
Open Access | Times Cited: 147
Resistant starch decreases intrahepatic triglycerides in patients with NAFLD via gut microbiome alterations
Yueqiong Ni, Lingling Qian, Sara Leal Siliceo, et al.
Cell Metabolism (2023) Vol. 35, Iss. 9, pp. 1530-1547.e8
Open Access | Times Cited: 73
Head-to-head comparison between MEFIB, MAST, and FAST for detecting stage 2 fibrosis or higher among patients with NAFLD
Beom Kyung Kim, Nobuharu Tamaki, Kento Imajo, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 6, pp. 1482-1490
Open Access | Times Cited: 72
Safety, pharmacokinetics, and pharmacodynamics of pegozafermin in patients with non-alcoholic steatohepatitis: a randomised, double-blind, placebo-controlled, phase 1b/2a multiple-ascending-dose study
Rohit Loomba, Eric Lawitz, Juan P. Frías, et al.
˜The œLancet. Gastroenterology & hepatology (2022) Vol. 8, Iss. 2, pp. 120-132
Closed Access | Times Cited: 69
Longitudinal Outcomes Associated With Metabolic Dysfunction-Associated Steatotic Liver Disease: A Meta-analysis of 129 Studies
Kai En Chan, Elden Yen Hng Ong, Charlotte Hui Chung, et al.
Clinical Gastroenterology and Hepatology (2023) Vol. 22, Iss. 3, pp. 488-498.e14
Closed Access | Times Cited: 51
Gender Differences and Cardiometabolic Risk: The Importance of the Risk Factors
Antonella Meloni, Christian Cadeddu Dessalvi, Lucia Cugusi, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 2, pp. 1588-1588
Open Access | Times Cited: 45
Gut microbiota and metabolic biomarkers in metabolic dysfunction–associated steatotic liver disease
Qichen Long, Fengming Luo, Binghui Li, et al.
Hepatology Communications (2024) Vol. 8, Iss. 3
Open Access | Times Cited: 20
Liver stiffness thresholds to predict disease progression and clinical outcomes in bridging fibrosis and cirrhosis
Rohit Loomba, Daniel Q. Huang, Arun J. Sanyal, et al.
Gut (2022) Vol. 72, Iss. 3, pp. 581-589
Open Access | Times Cited: 62
Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
Eirini Martinou, Marinos Pericleous, Irena Stefanova, et al.
Diagnostics (2022) Vol. 12, Iss. 2, pp. 407-407
Open Access | Times Cited: 48
Noninvasive assessment of liver fibrosis and its clinical significance in nonalcoholic fatty liver disease
Nobuharu Tamaki, Masayuki Kurosaki, Daniel Q. Huang, et al.
Hepatology Research (2022) Vol. 52, Iss. 6, pp. 497-507
Open Access | Times Cited: 46
Risk of advanced fibrosis in first-degree relatives of patients with nonalcoholic fatty liver disease
Nobuharu Tamaki, Noora Ahlholm, Panu K. Luukkonen, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 21
Open Access | Times Cited: 42
Non-invasive evaluation of liver steatosis with imaging modalities: New techniques and applications
Keyu Zeng, Wu-Yong-Ga Bao, Yunhan Wang, et al.
World Journal of Gastroenterology (2023) Vol. 29, Iss. 17, pp. 2534-2550
Open Access | Times Cited: 22
NAFLD in the 21st Century: Current Knowledge Regarding Its Pathogenesis, Diagnosis and Therapeutics
Dimitris Kounatidis, Natalia G. Vallianou, Eleni Geladari, et al.
Biomedicines (2024) Vol. 12, Iss. 4, pp. 826-826
Open Access | Times Cited: 12
Severity and Remission of Metabolic Dysfunction–Associated Fatty/Steatotic Liver Disease With Chronic Kidney Disease Occurrence
Jingli Gao, Yuhao Li, Yijun Zhang, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 5
Open Access | Times Cited: 11
Early and accurate diagnosis of steatotic liver by artificial intelligence (AI)-supported ultrasonography
Sérgio Santoro, Mohamad Khalil, Hala Abdallah, et al.
European Journal of Internal Medicine (2024) Vol. 125, pp. 57-66
Closed Access | Times Cited: 10
Natural history of lean and non-lean metabolic dysfunction-associated steatotic liver disease
Shun‐ichi Wakabayashi, Nobuharu Tamaki, Takefumi Kimura, et al.
Journal of Gastroenterology (2024) Vol. 59, Iss. 6, pp. 494-503
Closed Access | Times Cited: 9
Interleukin‐38 alleviates hepatic steatosis through AMPK/autophagy‐mediated suppression of endoplasmic reticulum stress in obesity models
Jaw Long Sun, Wonjun Cho, Heeseung Oh, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 4
Closed Access | Times Cited: 8
Longitudinal Magnetic Resonance Imaging with ROS‐Responsive Bilirubin Nanoparticles Enables Monitoring of Nonalcoholic Steatohepatitis Progression to Cirrhosis
Wonsik Jung, Muhammad Asaduddin, Hyeongseop Keum, et al.
Advanced Materials (2024) Vol. 36, Iss. 24
Closed Access | Times Cited: 8
Cardiometabolic criteria as predictors and treatment targets of liver‐related events and cardiovascular events in metabolic dysfunction‐associated steatotic liver disease
Nobuharu Tamaki, Takefumi Kimura, Shun‐ichi Wakabayashi, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 60, Iss. 8, pp. 1033-1041
Closed Access | Times Cited: 8
Longitudinal association of magnetic resonance elastography‐associated liver stiffness with complications and mortality
Mayu Higuchi, Nobuharu Tamaki, Masayuki Kurosaki, et al.
Alimentary Pharmacology & Therapeutics (2021) Vol. 55, Iss. 3, pp. 292-301
Open Access | Times Cited: 55
Exosomal RBP4 potentiated hepatic lipid accumulation and inflammation in high-fat-diet-fed mice by promoting M1 polarization of Kupffer cells
Jinmei Yao, Huazhong Ying, Huan‐Huan Zhang, et al.
Free Radical Biology and Medicine (2022) Vol. 195, pp. 58-73
Closed Access | Times Cited: 28
Nanoparticle-Based Activatable MRI Probes for Disease Imaging and Monitoring
Yifan Fan, Limin Chen, Yuanxi Zheng, et al.
Chemical & Biomedical Imaging (2023) Vol. 1, Iss. 3, pp. 192-204
Open Access | Times Cited: 21
Emerging nanotechnology for Alzheimer's disease: From detection to treatment
Nan Song, Si Sun, Ke Chen, et al.
Journal of Controlled Release (2023) Vol. 360, pp. 392-417
Closed Access | Times Cited: 20
Effect of exercise-based interventions in nonalcoholic fatty liver disease: A systematic review with meta-analysis
Heechul Nam, Jeong‐Ju Yoo, Yuri Cho, et al.
Digestive and Liver Disease (2023) Vol. 55, Iss. 9, pp. 1178-1186
Closed Access | Times Cited: 19
Page 1 - Next Page

Scroll to top